New treatment for advanced melanoma uses tumor to fight the disease
A treatment for advanced melanoma that's newly approved by the FDA is giving cancer patients new hope. Tumor-infiltrating lymphocyte, or "TIL" therapy, uses an individual's own tumor to help fight the disease.
Reported by 1 outlet — CBS News. See all sources ↓
A treatment for advanced melanoma that's newly approved by the FDA is giving cancer patients new hope. Tumor-infiltrating lymphocyte, or "TIL" therapy, uses an individual's own tumor to help fight the disease. CBS News' Natalie Brand reports.
Read the full report at CBS News ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- A treatment for advanced melanoma that's newly approved by the FDA is giving cancer patients new hope. Tumor-infiltrating lymphocyte, or "TIL" therapy, uses an individual's own tumor to help fight the disease.
- How widely is it covered?
- 1 outlet, average source rating 8.0/10.
- When was it last updated?
- 2m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
New treatment for advanced melanoma uses tumor to fight the disease
Sources1TypeCoverageCBS News